ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report)’s share price was up 2.3% during mid-day trading on Friday . The stock traded as high as $1.35 and last traded at $1.35. Approximately 161,767 shares were traded during trading, an increase of 696% from the average session volume of 20,327 shares. The stock had previously closed at $1.32.
ImmunoPrecise Antibodies Price Performance
The firm’s fifty day moving average price is $1.39 and its 200 day moving average price is $1.36.
About ImmunoPrecise Antibodies
ImmunoPrecise Antibodies Ltd (OTCMKTS:IPATF) is a Canada-based contract research organization specializing in the discovery and development of therapeutic antibodies. The company provides a full suite of preclinical research services, from target validation and lead identification through to humanization and optimization. Its capabilities encompass hybridoma, phage display, single B cell sorting and next-generation sequencing platforms to accelerate antibody candidate selection and characterization.
ImmunoPrecise serves biopharmaceutical and biotechnology partners worldwide, offering customized solutions for projects in immuno-oncology, infectious diseases, autoimmunity and other therapeutic areas.
Featured Articles
- Five stocks we like better than ImmunoPrecise Antibodies
- Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
- Optical Cable Corporation Is Starting to Get the Market’s Attention
- Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
- Is Nike’s Index Demotion a Warning or a Buying Opportunity?
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
